DIAGNOSTIC VALUE OF CARTILAGE OLIGOMERIC MATRIX PROTEIN IN CONNECTIVE TISSUE DISEASE


Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The paper gives data on the diagnostic value of cartilage oligomeric matrix protein in connective tissue disease. The authors briefly outline the results of their own investigation aimed at determining the level of this protein as a biomarker of cartilage metabolism in children with hip dysplasia.

Full Text

Restricted Access

About the authors

Yu. Belova

V.I. Razumovsky Saratov State Medical University

Email: sarniito_bsv@mail.ru

E. Gladilin

V.I. Razumovsky Saratov State Medical University

Email: sarniito_bsv@mail.ru

References

  1. Энгельс Ф. Диалектика природы / М.: Политическая литература, 1975.
  2. Соколова О.С. Протеомные исследования в биологии и медицине. Методическое пособие / М.: Изд-во: МГУ им. М.В. Ломоносова, 2005.
  3. Andersson M., Svensson B., Petersson I. et al. Early increase in serum-COMP is associated with joint damage progression over the first five years in patients with rheumatoid arthritis // BMC Musculoskelet Disord. - 2013; 2 (14): 229.
  4. Happonen K., Saxne T., Jacobsson L. et al. COMP-C3b complexes in rheumatoid arthritis with severe extraarticular manifestations // J. Rheumatol. -2013; 40 (12): 2001-5.
  5. Hidayat R., Isbagio H., Setyohadi B. et al. Correlation between receptor activator of nuclear factor-Kß ligand (RANKL), and osteoprotegerin (OPG) with cartilage degradation in rheumatoid arthritis patients // Acta Med. Indones. - 2014; 46 (1): 24-9.
  6. Christensen A., Lindegaard H., Horslev-Petersen K. et al. Cartilage oligomeric matrix protein associates differentially with erosions and synovitis and has a different temporal course in cyclic citrullinated peptide antibody (anti-CCP)-positive versus anti-CCP-negative early rheumatoid arthritis // J. Rheumatol. - 2011; 38 (8): 1563-8.
  7. Houseman M., Potter C., Marshall N. et al. Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8 years follow up // Arthritis Res Ther. - 2012; 14 (1): R30.
  8. Niki Y., Takeuchi T., Nakayama M. et al. Clinical significance of cartilage biomarkers for monitoring structural joint damage in rheumatoid arthritis patients treated with anti-TNF therapy // PLoS One. - 2012; 7 (5): e37447.
  9. Mobasheri A. Osteoarthritis year 2012 in review: biomarkers // Osteoarthritis Cartilage. - 2012; 20 (12): 1451-64.
  10. Lotz M., Martel-Pelletier J., Christiansen C. et al. Value of biomarkers in osteoarthritis: current status and perspectives // Ann. Rheum. Dis. - 2013; 72 (11): 1756-63.
  11. Wang X., Zheng Y., Cao Y. et al. Study on the diagnostic value of whole-organ magnetic resonance imaging score (WORMS) in knee osteoarthritis // Zhongguo Gu Shang. - 2012; 25 (5): 364-8.
  12. Williams F., Spector T. Biomarkers in osteoarthritis // Arthritis Res. Ther. -2008; 10 (1): 101.
  13. Li H., Wang D., Wu Z. et al. Serum levels of cartilage oligomeric matrix protein in the diagnosis of knee osteoarthritis // Zhongguo Gu Shang. - 2012; 25 (5): 380-3.
  14. Verma P., Dalal K. Serum cartilage oligomeric matrix protein (COMP) in knee osteoarthritis: a novel diagnostic and prognostic biomarker // J. Orthop. Res. -2013; 31 (7): 999-1006.
  15. Addison S., Coleman R., Feng S. et al. Whole-body bone scintigraphy provides a measure of the total-body burden of osteoarthritis for the purpose of systemic biomarker validation // Arthritis Rheum. - 2009; 60 (11): 3366-73.
  16. Vos L., Kuijer R., Huddleston Slater J. et al. Inflammation is more distinct in temporomandibular joint osteoarthritis compared to the knee joint // J. Maxillofac. Surg. - 2014; 72 (1): 35-40.
  17. Светлова М.С. Гонартроз ранних стадий: клинико-инструментальная, лабораторная характеристика и болезнь-модифицирующая терапия. Автореф. дис.. д-ра мед. наук. Ярославль, 2009.
  18. Zivanovic S., Rackov L., Zivanovic A. Cartilage oligomeric matrix protein -inflammation biomarker in knee osteoarthritis // Bosn. J. Basic Med. Sci. - 2011; 11 (1): 27-32.
  19. Posey K., Hecht J. The role of cartilage oligomeric matrix protein (COMP) in skeletal disease // Curr. Drug Targets. - 2008; 9 (10): 869-77.
  20. Спиридонов Н.А. Медико-социальные последствия у больных с врожденным вывихом бедра и современные подходы к их реабилитации. Автореф. дис.. канд. мед. наук. М., 2011.

Supplementary files

Supplementary Files
Action
1. JATS XML

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies